FABP7 has been shown to be involved in lipid metabolism in various tumors, particularly gliomas [7, 31], suggesting that the abnormal expression of FABP7 may influence the prognosis of patients with glioma and their response to treatment with the antiangiogenic agent apatinib. This evidence concerns the gene FABP7 and glioma.